TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy

TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy

Transforming growth factor β1 (TGFβ1) is a proinflammatory cytokine that has been implicated in the pathogenesis of diabetic retinopathy (DR), particularly in the late phase of disease. The aim of the present study was to validate serum TGFβ1 as a diagnostic and prognostic biomarker of DR stages. Th...

Full description

Bibliographic Details
Main Authors: Vincenza Bonfiglio, Chiara Bianca Maria Platania, Francesca Lazzara, Federica Conti, Corrado Pizzo, Michele Reibaldi, Andrea Russo, Matteo Fallico, Elina Ortisi, Francesco Pignatelli, Antonio Longo, Teresio Avitabile, Filippo Drago, Claudio Bucolo
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:International Journal of Molecular Sciences
Subjects:
diabetic retinopathy
serum biomarkers
anti-VEGFA
TGFβ
Online Access:https://www.mdpi.com/1422-0067/21/24/9558

Internet

https://www.mdpi.com/1422-0067/21/24/9558

Similar Items